General Information:

Id: 1,571 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type II - [OMIM]
Insulin resistance
Homo sapiens
Reference: Itoh M et al.(2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects Arterioscler. Thromb. Vasc. Biol. 27: 1918-1925 [PMID: 17569885]

Interaction Information:

Comment After three months of EPA treatment plasma TG concentrations were significantly decreased relative to the control group, although there were no changes in BMI, waist circumference, systolic blood pressure, fasting plasma glucose (FPG), total cholesterol, high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) between both groups.
Formal Description
Interaction-ID: 11252

drug/chemical compound

Eicosapentaenoic acid

NOT affects_quantity of

drug/chemical compound


in blood
Drugbank entries Show/Hide entries for